SOURCE: Wall Street Equity Research

Wall Street Equity Research

December 13, 2010 08:57 ET

General Overview on OriginOil Inc. and HepaLife Technologies Inc. -- Small Cap Research Companies Look to Make It Big

JOHANNESBURG, SOUTH AFRICA--(Marketwire - December 13, 2010) - gives shareholders valuable insight on research services stocks OriginOil Inc. (OTCBB: OOIL) and HepaLife Technologies Inc. (OTCBB: HPLF). Sign up today at to receive free research reports on these equities.

From healthcare to energy, companies involved in research services provide valuable advancements to sectors that rely on innovations to fuel grown and expansion. Two such small cap companies that are involved in different areas of the Research Services Industry are OriginOil Inc. and HepaLife Technologies Inc. Visit us at to understand the catalysts and forces driving or affecting the research services industry in today's economic environment. is a specialized website where investors can have specific access to free reports research services industry; traders looking for analyst opinions on OriginOil Inc., HepaLife Technologies Inc. and other companies in this industry are welcomed to sign up for a free one year membership at

OriginOil which has developed a process to convert algae into oil for plastics and fuel has been doing well recently. The company announced the successful completion of the first phase of their commercial pilot project. A full 80 hectare plant is projected to produce 11 million litres of oil. The company has also announced that they have been chosen by Sustainable Resources Inc. to assist in the construction of a new algae research center for the advancement of algae research for commercialization. Traders can get direct and free access to today's full report on OriginOil Inc. by signing up at

HepaLife Technologies is also looking towards innovation to fuel their company's growth. The company has recently announced that it has submitted a 501k application to the FDA for approval of their antimicrobial wound dressing. The dressing contains silver ions which the company claims kills bacteria. The company has also recently partnered up with Jeiven Pharmaceutical Consulting, Inc. to create a generic version of a transdemal pain patch. Traders can have complimentary access to today's complete research report on HepaLife Technologies Inc. by signing up at

About Wall Street Equity Research: 
Wall Street Equity Research looks to bring simplicity and highly sophisticated research to an ever-changing investing environment. Wall Street Equity Research has been partnering with a number of North American and Emerging Economies analysts to bring you the best of both continents in terms of market analysis and analytical opinions. 

Contact Information